EUVIMEDEUVIMED entdecken
Crossref

The Gut–Brain–Immune Axis in Chronic Disease: Mechanisms and Therapeutic Opportunities — A Narrative Synthesis

Integrative Biomedical Research · 01.04.2026 · 10 (1) · 1-8

DOI: 10.25163/biomedical.10110884 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Integrative Biomedical Research, online erschienen am 01.04.2026.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The gastrointestinal microbiota shapes host metabolism, immunity, and brain function through a tripartite gut–brain–immune axis, yet the field still lacks a unified synthesis linking barrier failure, immunometabolic signaling, and disease-specific outcomes. We conducted a structured narrative review of preclinical and clinical literature indexed largely through PubMed-listed sources, synthesizing evidence on neural, endocrine, immunological, and microbial-metabolite communication pathways and their dysregulation in Parkinson’s disease, Alzheimer’s disease, multiple sclerosis, and related chronic conditions. Across disorders, intestinal barrier failure and endotoxemia recur as a shared upstream trigger, converging on microglial activation, kynurenine pathway shunting toward neurotoxic quinolinic acid, and blood–brain barrier compromise, while each disease additionally shows a distinctive dysbiotic signature and cellular trafficking pattern—vagal alpha-synuclein propagation in Parkinson’s disease, amyloid cross-seeding in Alzheimer’s disease, and Th17-mediated demyelination in multiple sclerosis. Microbiome-directed interventions, including dietary modulation, psychobiotics, and fecal microbiota transplantation, showed measurable, if heterogeneous, benefit; a placebo-controlled fecal transplantation trial in Parkinson’s disease, for instance, reported meaningfully greater motor improvement than placebo. The evidence, taken together, supports the gut–brain–immune axis as a mechanistically coherent and therapeutically actionable framework, though translation remains constrained by engraftment variability and a scarcity of standardized, biomarker-guided trial designs. Personalized, multi-omics-informed strategies appear to be the most promising path toward clinical utility.

Zitieren

APA

(2026). The Gut–Brain–Immune Axis in Chronic Disease: Mechanisms and Therapeutic Opportunities — A Narrative Synthesis. Integrative Biomedical Research, 10(1), 1-8. https://doi.org/10.25163/biomedical.10110884

Vancouver

The Gut–Brain–Immune Axis in Chronic Disease: Mechanisms and Therapeutic Opportunities — A Narrative Synthesis. Integrative Biomedical Research. 2026;10(1):1-8. doi:10.25163/biomedical.10110884

BibTeX
@article{euvimed2026,
  title = {The Gut–Brain–Immune Axis in Chronic Disease: Mechanisms and Therapeutic Opportunities — A Narrative Synthesis},
  journal = {Integrative Biomedical Research},
  year = {2026},
  volume = {10},
  number = {1},
  pages = {1--8},
  doi = {10.25163/biomedical.10110884}
}
Kostenlos starten →